THU0363 Impact of adalimumab on clinical outcomes, healthcare resource utilization and sick leaves in ankylosing spondylitis patients in central and eastern europe
THU0363 Impact of adalimumab on clinical outcomes, healthcare resource utilization and sick leaves in ankylosing spondylitis patients in central and eastern europe